Navigation Links
Innovative Care Is Helping Iraq War's Injured Survive
Date:3/24/2008

Improvements mean 9 out of 10 with serious trauma live, often with little visible damage, surgeons say

MONDAY, March 24 (HealthDay News) -- After five years of war in Iraq, there's some relatively good medical news about the casualties over there: more than 90 percent are now surviving injuries that would have been fatal in previous conflicts.

In the March issue of The Journal of Craniofacial Surgery, the surgical and treatment advances behind these gains are discussed in special articles by craniofacial surgeons who specialize in head and facial trauma injuries -- cases involving noses and lips ripped away in bomb blasts, skulls and jaws shattered by bullets, and skin sheared off by burning debris.

"Trauma that results from war, and trauma we see in hospital wards from car crashes, gang fights and more, are two different things. But by integrating the knowledge of military and civilian surgeons we are improving outcomes for the casualties of modern war and saving the lives of people who would never have survived years ago," said Dr. Mutaz B. Habal, director of the Tampa Bay Craniofacial Center in Tampa, Fla., and the journal's editor-in-chief.

According to surgeons who reported their experiences in the journal, changes to treatment guidelines and protocols based on surgical insights, ongoing data collection and analyses have resulted in better treatments for the wounded. In addition, the introduction of civilian trauma experts and weekly video conferences have improved continuity of care for injured soldiers throughout the Military Health System and into the Veterans' Administration system.

"Application of these lessons into training doctrines for standards of practice will ensure optimal outcomes for our patients of today and into the future for soldiers and civilians alike, should the need ever arise," wrote JCS contributor Col. W. Bryan Gamble, M.D., of the U.S. Army Medical Corps.


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. ClearScript Offers Innovative Medication Therapy Management Program to Employee Health Plans
2. HHS Deputy Secretary Invites Toledo Community to Apply for an Innovative Electronic Health Record Demonstration Project
3. Prize or patent? Innovative ideas for funding medical drug development and access
4. VA to Pilot Innovative Remote Benefits Delivery Program
5. AARP Services Inc. and Genworth Financial Introduce New Innovative and Affordable Long Term Care Insurance Option to AARP Members
6. Burgerville Honored for Dedication to Employees and Innovative Workplace Practices
7. Vendormate Again Selected as Top 40 Georgia Innovative Technology Company
8. Emeril Lagasse and Planet Green Partner with Whole Foods Market(R) on Innovative New Series
9. Acuitecs Vigilance Product Wins Microsoft Award as Most Innovative Product for 2008
10. ARJO, Inc. Launches Two Innovative Products and New Campaign
11. Microsoft to Showcase Innovative Solutions for Healthcare Providers and Consumers at HIMSS 2008 Annual Conference & Exhibition
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Innovative Care Is Helping Iraq War's Injured Survive
Innovative Care Is Helping Iraq War's Injured Survive
Breaking Medicine Technology:FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8CBI Announces FDA Participation at Upcoming Forum on Clinical Trial Investigator Portals 14631 1CBI Announces FDA Participation at Upcoming Forum on Clinical Trial Investigator Portals 14631 2CBI Announces FDA Participation at Upcoming Forum on Clinical Trial Investigator Portals 14631 3Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 1Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 2Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 3Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 4Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 5Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 1Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 2Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 3